NCBIO members got an overview of the Food and Drug Administration’s regulatory environment for medical devices both during the pandemic and now at the NCBIO Medical Device Forum held May 11 at the NC Biotechnology Center. Robert Rosenthal, a partner with MED1 Ventures, moderated a panel... Continue Reading
On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the Biogen’s Alzheimer’s disease treatment Aduhelm — along with other drugs like it — to clinical trials. Michelle McMurry-Heath, M.D., Ph.D., president and CEO of... Continue Reading
Sam Taylor The Samuel M. Taylor Memorial Scholarship Fund created by NCBIO at the North Carolina Community Colleges Foundation Inc. has exceeded $200,000 in gifts and pledges with leadership gifts coming from Alexandria Real Estate Equities, Biogen and Hatteras Venture Partners. Grifols,... Continue Reading
A high quality board of directors and valuable outside partnerships are two advantages that biotech startups would do well to cultivate, according to the expert panelists assembled for the NCBIO Emerging Company and Technology Forum held Wednesday, March 16, at the NC Biotechnology... Continue Reading
Laura Gunter, Neil Jones, Celeste Warren and Shaylah Nunn-Jones NCBIO members gathered at the NC Biotechnology Center Wednesday, March 9, to seek inspiration and guidance in pursuing their companies’ diversity, equity and inclusion goals. Some key takeaways from the... Continue Reading
The biotech and life sciences industry is coming together to donate a range of critical medical supplies, equipment, and medications to the people of Ukraine. "The conflict in Ukraine and violence from Russia defies international law, norms and modern sensibilities,” said BIO President... Continue Reading
At the NCBIO Biotech Manufacturers Forum held online Feb. 23, representatives from FUJIFILM Diosynth Biotechnologies, Lilly and Project Farma shared what they had learned about commissioning new facilities and equipment during the during the COVID-19 pandemic. Presenting at the meeting were... Continue Reading
Life Science Caucus tours NC Reseach Campus in Kannapolis Members of the NC Life Science Caucus toured the NC Research Campus in Kannapolis on Wednesday, Feb. 23, along with local leaders and representatives of industry, such as Eli Lilly and Company, which is setting up shop in nearby... Continue Reading
Rep. Deborah Ross answers questions from NCBIO members Feb. 14 at NCBiotech. Immigration reform, protection of intellectual property, the threat of antimicrobial resistance, workforce training and more were topics covered by Rep. Deborah Ross at an NCBIO legislative round table held Monday,... Continue Reading
The Biotechnology Innovation Organization, in partnership with the Council of State Bioscience Associations, released a new report on bioscience economic development best practices, “Driving the Bioscience Economy Forward During the COVID-19 Pandemic: Best Practices in State and Regional... Continue Reading
Sen. Thom Tillis addressed manufacturing capacity, China, intellectual property protections, workforce development and more with NCBIO members during a legislative forum held online Friday, Jan. 14. He emphasized that he and his staff were eager to hear the concerns, issues and ideas of North... Continue Reading
Who pays to create new medicines? The share of private money invested in developing new medicines approved by the FDA in 2020 exceeded the entire budget of the National Institutes of Health by about 6,500%, according to a new study by Vital Transformation. Vital Transformation... Continue Reading
